[Urinary excretion of thromboxane B2 in the genetically hypertensive rat of the Lyons strain].
In order to assess the pathophysiological role of the renal Thromboxane (Tx)A2 in genetic hypertension, the urinary excretion of its stable metabolite: the TxB2 was followed in groups of 12 hypertensive (LH), normotensive (LN) and low blood pressure (LL) female rats of the Lyon strains at the ages of 5, 9, 21 and 32 weeks. In the 3 strains studied, the urinary TxB2 excretion markedly decreased between 5 and 9 weeks of age and did change thereafter. In addition, 5 and 9 weeks old rats exhibited an increased urinary TxB2 output compared to LN and LL controls. Since TxA2 is a potent vasoconstrictor, it seems likely to hypothesize that the early increase observed in the renal TxA2 biosynthesis could be one of the primary events occurring during the development of hypertension in this rat model.
D000375:Aging / Q000652:urine; D000818:Animals; D001835:Body Weight; D005260:Female; D006973:Hypertension / Q000235:genetics / Q000378:metabolism / Q000652:urine*; D007668:Kidney / Q000378:metabolism; D051381:Rats; D013928:Thromboxane A2 / Q000096:biosynthesis; D013929:Thromboxane B2 / Q000652:urine*
D013929:Thromboxane B2; D013928:Thromboxane A2
Excrétion urinaire du thromboxane B2 chez le rat génétiquement hypertendu de la souche lyonnaise.